
Topic
Payer Policy
Medicare, commercial payer, PBM, and formulary-policy moves that shape launch curves and gross-to-net.

Pricing & Access· May 31, 2026 · 12 min read
By Ran Chen#GLP-1#Prior Authorization#Specialty Drugs

Biosimilars· May 31, 2026 · 12 min read
Interchangeable biosimilar substitution notices and state-law workflow
By Ran Chen#Biosimilars#Interchangeability#Payer Policy

Specialty· May 31, 2026 · 11 min read
Limited distribution specialty pharmacy lockout and payer mandates

Pricing & Access· May 31, 2026 · 15 min read
Medicare GLP-1 Bridge PA evidence file and documentation
By Ran Chen#GLP-1#Medicare Part D#Prior Authorization

Pricing & Access· May 31, 2026 · 13 min read
Medicare GLP-1 Bridge patient ineligibility traps
By Ran Chen#Medicare Part D#GLP-1#Prior Authorization

Pricing & Access· May 31, 2026 · 11 min read
Medicare Part D transition fill vs manufacturer bridge programs

Pricing & Access· May 31, 2026 · 14 min read
MFP refund dispute workflow for dispensing entities

Pricing & Access· May 31, 2026 · 9 min read
Oral GLP-1 launch access checklist: payer team readiness before approval
By Ran Chen#GLP-1#Oral GLP-1#Payer Policy

Pricing & Access· May 31, 2026 · 9 min read
Payer-mandated biosimilar switch communication and nocebo risk
By Ran Chen#Biosimilars#Payer Policy#Formulary Strategy

Specialty· May 31, 2026 · 10 min read